Pages that link to "Q70062828"
Jump to navigation
Jump to search
The following pages link to Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors (Q70062828):
Displaying 39 items.
- TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1 (Q24529076) (← links)
- A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer (Q33407185) (← links)
- The somatostatin analog Sandostatin (SMS201-995) in treatment of DMBA-induced rat mammary tumors (Q33490969) (← links)
- Autocrine growth factors and solid tumor malignancy. (Q33559452) (← links)
- Differential expression of growth factor receptors and membrane-bound tumor markers for imaging in male and female breast cancer (Q34544957) (← links)
- Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice (Q34898828) (← links)
- Mechanisms of obesity-induced gastrointestinal neoplasia (Q35062195) (← links)
- Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients (Q35100621) (← links)
- The role of the insulin-like growth factor-1 system in breast cancer (Q35105295) (← links)
- Interference of the IGF system as a strategy to inhibit breast cancer growth (Q35465033) (← links)
- IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence (Q35465090) (← links)
- Type 1 IGF receptor in human breast diseases (Q35465137) (← links)
- Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer cells (Q35465155) (← links)
- Tamoxifen reduces serum insulin-like growth factor I (IGF-I) (Q35465195) (← links)
- Insulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer. (Q35586993) (← links)
- Insulin-like growth factor 1 receptors in human breast tumour: localisation and quantification by histo-autoradiographic analysis (Q35994133) (← links)
- Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature (Q36081908) (← links)
- Fatty metamorphosis of the liver in patients with breast cancer: possible associated factors (Q36190793) (← links)
- Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases (Q36223424) (← links)
- Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up (Q36295053) (← links)
- Breast cancer: further metabolic-endocrine risk markers? (Q36431629) (← links)
- Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer (Q36583516) (← links)
- Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer (Q36623079) (← links)
- Enhancement of transforming potential of human insulinlike growth factor 1 receptor by N-terminal truncation and fusion to avian sarcoma virus UR2 gag sequence (Q36656168) (← links)
- Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells (Q36699583) (← links)
- The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulinlike growth factor 1 with its receptor (Q36705005) (← links)
- The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer (Q36955067) (← links)
- The potential role of somatostatin analogues in breast cancer treatment (Q36988009) (← links)
- Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer. (Q37340004) (← links)
- Regulation of insulin-like growth factors by antiestrogen (Q40395035) (← links)
- Alternative mechanisms of action of anti-oestrogens (Q40644022) (← links)
- Dairy products and breast cancer: the IGF-I, estrogen, and bGH hypothesis (Q41554657) (← links)
- Effects of Hormones on Tumor Growth and Immunoreactive Insulin-like Growth Factor-1 of Estrogen Receptor-positive Human Breast Cancer (MCF-7) Transplanted in Nude Mice (Q41658460) (← links)
- Breast cancer: the obesity connection (Q42389309) (← links)
- IGF and insulin receptor signaling in breast cancer. (Q46240548) (← links)
- The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma. (Q55139939) (← links)
- Effect of two 4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer (Q60168387) (← links)
- Insulin-like growth factors and cancer (Q67487325) (← links)
- Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas (Q79079222) (← links)